0.00Open0.00Pre Close0 Volume0 Open Interest64.00Strike Price0.00Turnover147.16%IV-20.03%PremiumDec 27, 2024Expiry Date16.04Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9561Delta0.0085Gamma5.20Leverage Ratio-0.1429Theta0.0052Rho4.97Eff Leverage0.0069Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet